# reload+after+2024-01-20 20:44:31.169638
address1§142 North Cedros Avenue
address2§Suite B
city§Solana Beach
state§CA
zip§92075
country§United States
phone§858 925 8215
website§https://effector.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors and in combination with fulvestrant and abemaciclib in a Phase 2a open-label expansion cohort to treat patients with ER+ breast cancer. eFFECTOR Therapeutics, Inc. has a research collaboration and license agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.
fullTimeEmployees§15
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Stephen T. Worland Ph.D.', 'age': 65, 'title': 'CEO, President & Director', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 855255, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael  Byrnes M.B.A.', 'age': 46, 'title': 'Chief Financial Officer', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 623690, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Douglas  Warner M.D.', 'age': 51, 'title': 'Chief Medical Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 304400, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Davide  Ruggero Ph.D.', 'title': 'Co-Founder and Member of Clinical & Scientific Advisory Board', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Kevan M. Shokat Ph.D.', 'title': 'Co-Founder and Member of Clinical & Scientific Advisory Board', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Mayank J. Gandhi M.D.', 'age': 45, 'title': 'Chief Business Officer', 'yearBorn': 1978, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.367
priceToSalesTrailing12Months§50.83637
currency§USD
dateShortInterest§1702598400
forwardEps§-0.44
exchange§NCM
quoteType§EQUITY
shortName§eFFECTOR Therapeutics, Inc.
longName§eFFECTOR Therapeutics, Inc.
firstTradeDateEpochUtc§1614609000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§2ce11303-d138-3e2f-abbd-b04b9d454ccb
gmtOffSetMilliseconds§-18000000
targetHighPrice§7.0
targetLowPrice§5.0
targetMeanPrice§5.8
targetMedianPrice§5.4
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§3
quickRatio§0.755
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
